Tacrolimus is a medication used in the prevention and treatment of solid-organ transplant rejection. It is in the calcineurin-inhibitor class of medications. This activity outlines the indications, action, and contraindications for tacrolimus as a valuable agent in preventing solid-organ transplant rejection (and other disorders when applicable). This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the management and care of patients post solid-organ transplant.
Copyright © 2025, StatPearls Publishing LLC.